Troy Cox - Net Worth and Insider Trading
Troy Cox Net Worth
The estimated net worth of Troy Cox is at least $33 Million dollars as of 2024-11-13. Troy Cox is the CEO of Foundation Medicine Inc and owns about 242,068 shares of Foundation Medicine Inc (FMI) stock worth over $33 Million. Troy Cox is also the Director of Zymeworks Inc and owns about 7,500 shares of Zymeworks Inc (ZYME) stock worth over $130,500. Details can be seen in Troy Cox's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Troy Cox has not made any transactions after 2020-01-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Troy Cox
Troy Cox Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Troy Cox owns 3 companies in total, including Zymeworks Inc (ZYME) , Foundation Medicine Inc (FMI) , and SomaLogic Inc (SLGC) .
Click here to see the complete history of Troy Cox’s form 4 insider trades.
Insider Ownership Summary of Troy Cox
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZYME | Zymeworks Inc | 2022-12-21 | director |
| FMI | Foundation Medicine Inc | 2018-07-31 | director & President and CEO |
| SLGC | SomaLogic Inc | 2021-10-27 | director |
Troy Cox Latest Holdings Summary
Troy Cox currently owns a total of 2 stocks. Among these stocks, Troy Cox owns 242,068 shares of Foundation Medicine Inc (FMI) as of July 2, 2018, with a value of $33 Million and a weighting of 99.61%. Troy Cox also owns 7,500 shares of Zymeworks Inc (ZYME) as of January 27, 2020, with a value of $130,500 and a weighting of 0.39%.
Latest Holdings of Troy Cox
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FMI | Foundation Medicine Inc | 2018-07-02 | 242,068 | 137.00 | 33,163,316 |
| ZYME | Zymeworks Inc | 2020-01-27 | 7,500 | 17.40 | 130,500 |
Holding Weightings of Troy Cox
Troy Cox Form 4 Trading Tracker
According to the SEC Form 4 filings, Troy Cox has made a total of 0 transactions in Foundation Medicine Inc (FMI) over the past 5 years. The most-recent trade in Foundation Medicine Inc is the sale of 1,402 shares on July 2, 2018, which brought Troy Cox around $191,597.
According to the SEC Form 4 filings, Troy Cox has made a total of 1 transactions in Zymeworks Inc (ZYME) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Zymeworks Inc is the acquisition of 7,500 shares on January 27, 2020, which cost Troy Cox around $348,750.
Insider Trading History of Troy Cox
- 1
Troy Cox Trading Performance
GuruFocus tracks the stock performance after each of Troy Cox's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Troy Cox is -13.17%. GuruFocus also compares Troy Cox's trading performance to market benchmark return within the same time period. The performance of stocks bought by Troy Cox within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Troy Cox's insider trading performs compared to the benchmark.
Performance of Troy Cox
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.98 | | | | | |
| Relative Return to S&P 500(%) | -1.81 | | | | | |
Troy Cox Ownership Network
Ownership Network List of Troy Cox
Ownership Network Relation of Troy Cox
Troy Cox Owned Company Details
What does Zymeworks Inc do?
Who are the key executives at Zymeworks Inc?
Troy Cox is the director of Zymeworks Inc. Other key executives at Zymeworks Inc include director & Chair & CEO Kenneth Galbraith , SVP & Chief Financial Officer Christopher Astle , and Chief Scientific Officer Paul Andrew Moore .
Zymeworks Inc (ZYME) Insider Trades Summary
Over the past 18 months, Troy Cox made no insider transaction in Zymeworks Inc (ZYME). Other recent insider transactions involving Zymeworks Inc (ZYME) include a net sale of 6,880 shares made by Christopher Astle , a net purchase of 3,350,000 shares made by Ecor1 Capital, Llc , and a net sale of 23,904 shares made by Kenneth Galbraith .
In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,583 shares of Zymeworks Inc (ZYME) were sold and 3,350,000 shares were bought by its insiders, resulting in a net purchase of 3,309,417 shares.
Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zymeworks Inc Insider Transactions
Troy Cox Mailing Address
Above is the net worth, insider trading, and ownership report for Troy Cox. You might contact Troy Cox via mailing address: C/o Foundation Medicine, Inc., C/o Foundation Medicine, Inc., 150 Secon, Cambridge Ma 02141.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
